Company intelligence / Profile preview

Tereos

Ownership: Private
Employees: ~15000
Development stage: Commercial

Overview

Tereos is a leading European cooperative specializing in the processing of agricultural raw materials into sugars, starches, dietary fibers, and plant proteins. The company supplies fully traceable sucrose and starch-based excipients and actives to the pharmaceutical industry for use in solid/liquid dosage forms, medicated confectionery, enteral/parenteral nutrition, and dialysis. Their Actilight® oligofructose fiber has been validated by over 100 clinical studies for benefits to gut health and metabolism[2][5][6].

Therapeutic areas: GastroenterologyNephrology
Modalities: Excipients (sucrose, starch-based)Active pharmaceutical ingredients (glucose monohydrate)Dietary fibers (oligofructose/fructooligosaccharide)
Industry: Agriculture & AgTech

Partnerships

Futerro (biofuels/plant chemistry partnership)[7]Danone (innovation partner)[9]

Beyond the preview

Go deeper on Tereos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tereos.

Explore the full profile